Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process - Archive ouverte HAL
Article Dans Une Revue Journal of Clinical Medicine Année : 2021

Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process

1 LA CONCEPTION - Hôpital de la Conception [CHU - APHM]
2 IMBE - Institut méditerranéen de biodiversité et d'écologie marine et continentale
3 Unité d’Epidémiologie Clinique, Hôpital Universitaire Robert Debré, AP-HP Nord-Université de Paris, Inserm, CIC 1426, 75019 Paris, France
4 ECEVE (U1123 / UMR_S_1123) - Epidémiologie Clinique et Evaluation Economique Appliquées aux Populations Vulnérables
5 GRC 6 - C3E - Groupe de recherche clinique Centre Expert en Endométriose
6 CHU Tenon [AP-HP]
7 Service de Gynécologie et Obstétrique [CHU Rouen]
8 IC UM3 (UMR 8104 / U1016) - Institut Cochin
9 Department of Gynecology-Obstetric, UFR SMBH Leonard de Vinci, CH René Dubos, 95000 Cergy-Pontoise, France
10 Université Sorbonne Paris Nord—Paris 13, 93200 Saint-Denis, France
11 Institut Francophone de Recherche et d’Etudes Appliquées à la Reproduction, Ifreares Toulouse, 31000 Toulouse, France
12 Service de Gynécologie [CHU Clermont-Ferrand]
13 Clinique Saint Roch, Department of Gynecology-Obstetric and Reproductive Medicine, 34000 Montpellier, France
14 Department of Reproductive Medicine and Fertility Preservation, AP-HP Hôpital Jean Verdier, 93143 Bondy
15 Centre d’Endométriose [Clinique Tivoli Ducos, Bordeaux]
16 EndoFrance, Association Française de lutte contre l’Endométriose, 70190 Tresilley, France
17 Department of Gynecology-Obstetric and Reproductive Medicine, CHU Poitiers, 86000 Poitiers, France
18 CIC 1402 - CIC Poitiers – Centre d'investigation clinique de Poitiers
19 Department of Gynecology-Obstetric, CH Moulins Yzeure, 03000 Moulins, France
20 Department of Gynecology and Obstetrics, CHI Poissy-Saint-Germain-en Laye, 78300 Poissy
21 Research Unit 7285 Risk and Safety in ClinicalMedicine forWomen and Perinatal Health, Paris-Saclay University, 78300 Poissy, France
Catherine Patrat
  • Fonction : Auteur
  • PersonId : 1109429

Résumé

International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification—in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.
Fichier principal
Vignette du fichier
COURBIERE 2021.pdf (931.55 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03335898 , version 1 (06-09-2021)

Identifiants

Citer

Blandine Courbiere, Enora Le Roux, Emmanuelle Mathieu D’argent, Antoine Torre, Catherine Patrat, et al.. Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process. Journal of Clinical Medicine, 2021, 10 (17), pp.3810. ⟨10.3390/jcm10173810⟩. ⟨hal-03335898⟩
88 Consultations
148 Téléchargements

Altmetric

Partager

More